Alpine Associates Management’s SpringWorks Therapeutics SWTX Stock Holding History

Alpine Associates Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,149,000	Closed	-$54M	–	94
2025 Q2	$54M	Buy	1,149,000 +949,500	+476%	+$42.2M	2.88%	8
2025 Q1	$8.8M	Buy	+199,500	New	+$9.18M	0.46%	41

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Alpine Associates Management's SWTX Position: Q3 2025 in Review

Alpine Associates Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 1,149,000 shares — an estimated $54M sold.

Alpine Associates Management first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $54M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Alpine Associates Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Alpine Associates Management sold 1,149,000 SpringWorks Therapeutics shares in Q3 2025, an estimated $54M.
Alpine Associates Management first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
Alpine Associates Management's SpringWorks Therapeutics position peaked at $54M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Alpine Associates Management's 13F filing for Q3 2025, filed 6 Nov 2025.